Tuberculosis is the world's leading infectious disease killer, and prevention is essential to successful TB control. Mycobacterium tuberculosis infection primarily affects the lungs, and M. tuberculosis infection can remain inactive (latent) for months or years without detection. Advanced tuberculosis tests (TB tests) that aid in the detection of latent TB infection can significantly reduce the risk of TB disease and can help prevent new outbreaks from recent transmission.
Newer latent TB test kits, known as Interferon-Gamma Release Assays (IGRAs), produce more accurate results than the century-old tuberculin skin test. Automated TB testing using chemiluminescent (CLIA) assays can streamline your testing workflow and increase test throughput.